10-Q/A Filing

ENVERIC BIOSCIENCES, INC. CIK: 890821 Q1 2012

Filing Information

Form Type	10-Q/A
Accession Number	`0001477932-12-001459`
Period End Date	20120331
Filing Date	20120510
Fiscal Year	2012
Fiscal Period	Q1
XBRL Instance	spzr-20120331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 42 Income Statement 14 Cash Flow Statement 24

Balance Sheet 42 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.13K	USD	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.15K	USD	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$6.09K	USD	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$18.23K	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, authorized shares	`PreferredStockSharesAuthorized`	1.00M	shares	Point-in-time
Preferred stock, authorized shares	`PreferredStockSharesAuthorized`	1.00M	shares	Point-in-time
Other Current Assets	`OtherAssetsCurrent`	$4.22K	USD	Point-in-time
Other Current Assets	`OtherAssetsCurrent`	$4.22K	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$10.30K	USD	Point-in-time
Preferred stock, issued shares	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Total Current Assets	`AssetsCurrent`	$22.45K	USD	Point-in-time
Preferred stock, issued shares	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Total Assets	`Assets`	$22.45K	USD	Point-in-time
Preferred stock, outstanding shares	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Total Assets	`Assets`	$10.30K	USD	Point-in-time
Preferred stock, outstanding shares	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, authorized shares	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Common stock, authorized shares	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Common stock, issued shares	`CommonStockSharesIssued`	12.14M	shares	Point-in-time
Common stock, issued shares	`CommonStockSharesIssued`	12.14M	shares	Point-in-time
Accounts Payable and Accrued Liabilities	`AccountsPayableAndAccruedLiabilities`	$9.79K	USD	Point-in-time
Accounts Payable and Accrued Liabilities	`AccountsPayableAndAccruedLiabilities`	$17.89K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$9.79K	USD	Point-in-time
Common stock, outstanding shares	`CommonStockSharesOutstanding`	12.14M	shares	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$17.89K	USD	Point-in-time
Common stock, outstanding shares	`CommonStockSharesOutstanding`	12.14M	shares	Point-in-time
Commitments and Contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common shares, $.01 par value, 300,000,000 shares authorized, 12,142,000shares issued and outstanding	`CommonStockValue`	$121.42K	USD	Point-in-time
Common shares, $.01 par value, 300,000,000 shares authorized, 12,142,000shares issued and outstanding	`CommonStockValue`	$121.42K	USD	Point-in-time
Additional Paid-In Capital	`AdditionalPaidInCapitalCommonStock`	$47.25M	USD	Point-in-time
Additional Paid-In Capital	`AdditionalPaidInCapitalCommonStock`	$47.25M	USD	Point-in-time
Accumulated Deficit	`RetainedEarningsAccumulatedDeficit`	$-47.37M	USD	Point-in-time
Accumulated Deficit	`RetainedEarningsAccumulatedDeficit`	$-47.37M	USD	Point-in-time
Total Shareholders' Equity	`StockholdersEquity`	$4.55K	USD	Point-in-time
Total Shareholders' Equity	`StockholdersEquity`	$510.00	USD	Point-in-time
Total Liabilities and Stockholders' Equity (Deficit)	`LiabilitiesAndStockholdersEquity`	$10.30K	USD	Point-in-time
Total Liabilities and Stockholders' Equity (Deficit)	`LiabilitiesAndStockholdersEquity`	$22.45K	USD	Point-in-time

Income Statement 14 line items

Line Item	Tag	Value	Unit	Period
General and Administrative	`GeneralAndAdministrativeExpense`	$11.08K	USD	1 Quarter
General and Administrative	`GeneralAndAdministrativeExpense`	$4.04K	USD	1 Quarter
Operating Loss	`OperatingIncomeLoss`	$-4.04K	USD	1 Quarter
Operating Loss	`OperatingIncomeLoss`	$-11.08K	USD	1 Quarter
Loss Before Income Taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-11.08K	USD	1 Quarter
Loss Before Income Taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-4.04K	USD	1 Quarter
Income Taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Income Taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Net (Loss)	`NetIncomeLoss`	$-11.08K	USD	1 Quarter
Net (Loss)	`NetIncomeLoss`	$-4.04K	USD	1 Quarter
Basic and Diluted Loss Per Share	`EarningsPerShareBasicAndDiluted`	-	USD	1 Quarter
Basic and Diluted Loss Per Share	`EarningsPerShareBasicAndDiluted`	-	USD	1 Quarter
Weighted Average Shares Outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	12.14M	shares	1 Quarter
Weighted Average Shares Outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	6.50M	shares	1 Quarter

Cash Flow Statement 24 line items

Line Item	Tag	Value	Unit	Period
Net Loss	`NetIncomeLoss`	$-11.08K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-4.04K	USD	1 Quarter
Other Current Assets	`IncreaseDecreaseInOtherCurrentAssets`	-	USD	1 Quarter
Other Current Assets	`IncreaseDecreaseInOtherCurrentAssets`	$-4.34K	USD	1 Quarter
Accounts Payable and Accrued Liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-1.54K	USD	1 Quarter
Accounts Payable and Accrued Liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-8.10K	USD	1 Quarter
Net Cash Used In Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-16.97K	USD	1 Quarter
Net Cash Used In Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-12.14K	USD	1 Quarter
Loans From Shareholders	`LoansFromShareholders`	-	USD	1 Quarter
Loans From Shareholders	`LoansFromShareholders`	$18.00K	USD	1 Quarter
Increase (decrease) in Cash and Cash Equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-12.14K	USD	1 Quarter
Increase (decrease) in Cash and Cash Equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$1.03K	USD	1 Quarter
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$1.13K	USD	Point-in-time
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$2.15K	USD	Point-in-time
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$6.09K	USD	Point-in-time
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$18.23K	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$1.13K	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$2.15K	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$6.09K	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$18.23K	USD	Point-in-time
Interest	`InterestPaid`	-	USD	1 Quarter
Interest	`InterestPaid`	-	USD	1 Quarter
Income Taxes	`IncomeTaxesPaid`	-	USD	1 Quarter
Income Taxes	`IncomeTaxesPaid`	-	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.